A COVID-19 vaccine from Sinopharm unit Beijing Institute of Biological Products has obtained approval to be used on people aged between three and 17 in China, a disease control official said on Friday.
Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, was speaking to reporters at a news briefing.
Read the latest updates in our dedicated coronavirus section.
Read more:
Abu Dhabi requires COVID-19 vaccine, negative PCR test to enter public places
Pfizer to test COVID-19 vaccine in larger group of children under age 12
UAE, Bahrain make Pfizer/BioNTech shot available to those who got Sinopharm vaccine
